Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 20, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

4E-BP2 hardwires lymphocytes for rapamycin sensitivity.

Robert T Abraham¹

¹Oncology-Rinat Research and Development Group, Pfizer Worldwide Research and Development, 10646 Science Center Drive/CB4, San Diego, CA 92121, USA. robert.abraham@pfizer.com.

Science Signaling

|June 2, 2016

Summary

Rapamycin inhibits lymphocyte growth by targeting 4E-BP2, a protein regulating translation. This specific 4E-BP2 isoform in lymphocytes is more sensitive to rapamycin, blocking T and B cell proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth.

Cancer discovery·2025

Same author

Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Nature·2024

Same author

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Nature·2024

Same author

Direct control of CAR T cells through small molecule-regulated antibodies.

Nature communications·2021

Same author

Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells.

Cell cycle (Georgetown, Tex.)·2020

Same author

Anti-tumor immunity influences cancer cell reliance upon ATG7.

Oncoimmunology·2020

Area of Science:

Immunology
Molecular Biology
Cell Biology

Background:

The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth and proliferation.
Rapamycin is a known inhibitor of mTORC1 and affects lymphocyte function.
Messenger RNA translation is a critical process for protein synthesis and cell function.

Purpose of the Study:

To investigate the specific effects of rapamycin on lymphocyte translation regulation.
To identify the key molecular targets of rapamycin in T and B lymphocytes.
To understand the differential sensitivity of 4E-BP isoforms to rapamycin in lymphoid versus nonlymphoid cells.

Main Methods:

Analysis of 4E-binding protein (4E-BP) isoform sensitivity to rapamycin.
Assessment of messenger RNA translation regulation in lymphocytes.

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Mar 20, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Evaluation of lymphocyte growth and proliferation inhibition by rapamycin.

Main Results:

The 4E-BP2 isoform, found in lymphocytes, is more sensitive to rapamycin than 4E-BP isoforms in nonlymphoid cells.
Inhibition of 4E-BP2 by rapamycin effectively blocks T and B lymphocyte growth.
Rapamycin's potent inhibition of lymphocyte proliferation is mediated through its effects on 4E-BP2.

Conclusions:

4E-BP2 is a critical mediator of rapamycin's inhibitory effects on lymphocyte proliferation.
Targeting 4E-BP2 represents a key mechanism by which rapamycin controls T and B cell growth.
These findings highlight the specific role of 4E-BP2 in lymphocyte biology and rapamycin's action.